Advertisement
Research Article Free access | 10.1172/JCI118168
Division of Geographic Medicine and Infectious Diseases, Tupper Research Institute, New England Medical Center, Boston, Massachusetts 02111, USA.
Find articles by Jacewicz, M. in: JCI | PubMed | Google Scholar
Division of Geographic Medicine and Infectious Diseases, Tupper Research Institute, New England Medical Center, Boston, Massachusetts 02111, USA.
Find articles by Acheson, D. in: JCI | PubMed | Google Scholar
Division of Geographic Medicine and Infectious Diseases, Tupper Research Institute, New England Medical Center, Boston, Massachusetts 02111, USA.
Find articles by Mobassaleh, M. in: JCI | PubMed | Google Scholar
Division of Geographic Medicine and Infectious Diseases, Tupper Research Institute, New England Medical Center, Boston, Massachusetts 02111, USA.
Find articles by Donohue-Rolfe, A. in: JCI | PubMed | Google Scholar
Division of Geographic Medicine and Infectious Diseases, Tupper Research Institute, New England Medical Center, Boston, Massachusetts 02111, USA.
Find articles by Balasubramanian, K. in: JCI | PubMed | Google Scholar
Division of Geographic Medicine and Infectious Diseases, Tupper Research Institute, New England Medical Center, Boston, Massachusetts 02111, USA.
Find articles by Keusch, G. in: JCI | PubMed | Google Scholar
Published September 1, 1995 - More info
Differentiated villus intestinal epithelial cells express globotriaosylceramide, the Shiga-like toxin 1 (SLT-1) receptor, and are sensitive to toxin-mediated cytotoxicity, whereas undifferentiated crypt cells neither express Gb3 nor respond to toxin. To investigate if SLT-1 receptors are maturationally regulated in human intestinal cells, we examined the effect of butyrate, a known transcriptional regulator of differentiation genes in many cell types, using cultured colonic cancer-derived epithelial cell lines. Exposure to butyrate increased villus cell marker enzymes such as alkaline phosphatase, sucrase, and lactase, expression of toxin receptors, and sensitivity to SLT-1 in villus-like CaCo-2A and HT-29 cells. These effects were reversibly inhibited by preincubation of CaCo-2A cells with actinomycin D or cycloheximide. Butyrate-treated CaCo-2A cells unable to bind fluoresceinated SLT-1 B subunit were undifferentiated as assessed by alkaline phosphatase activity. HT-29 cells induced to differentiate by another signal, glucose deprivation, upregulated receptor content and response to toxin. Crypt-like T-84 cells responded to butyrate with a modest increase in alkaline phosphatase and toxin binding, but no induction of sucrase or lactase, and no change in sensitivity to toxin. The results demonstrate that expression of SLT-1 toxin receptors and toxin sensitivity are coregulated with cellular differentiation in cultured intestinal cells.
Images.